15th Annual Cardiovascular Disease Update

Full-day session entitled the "15th Annual Update on Cardiovascular Disease" will be held on Oct 15th. The highly-anticipated return of this annual event will feature the very latest treatments available for every facet of cardiovascular disease. Tracks include complex valvular and aortic disorders, electrical disorders, emerging approaches in prevention, contemporary management of vascular diseases, and state-of-the-art approaches in heart failure and shock. The target audience includes cardiologists, endocrinologists, vascular surgeons, internists and family practitioners as well as fellows, residents, nurses, cardiac sonographers, NPs, PAs and others who direct large clinical practices and/or teach in academic medical institutions.    At the end of the conference, participants will be fully capable of taking this new information back to their communities and sharing it with their colleagues.

Agenda details can be found here:  https://cme.uhhospitals.org/15th-annual-cardiovascular-disease-update

Saturday, October 15, 2022, 8:00 AM - 3:15 PM, Tinkham Veale University Center, Cleveland, OH

1. • Examine the impact of emerging treatment approaches in complex patients with structural heart disease, arrhythmias, and heart failure
2. • Assess the latest diagnostic approaches to helping guide treatment approaches
3. • Review the latest information in devices and new technologies
4. • Utilize guideline and evidence-based strategies to lower risk

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mitigation of Relevant Financial Relationships

CWRU School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.